Ocular toxicity of systemic anticancer chemotherapy

Fuente: Redalyc
Saved in:
Bibliographic Details
Main Author: Afekhide Ernest Omoti
Format: Artículo científico
Language:en
Published: Centro de investigaciones y Publicaciones Farmacéuticas 2006
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1876451448109137920
author Afekhide Ernest Omoti
author_facet Afekhide Ernest Omoti
contents Ocular toxicity of systemic anticancer chemotherapy Afekhide Ernest Omoti Caroline Edijana Omoti Medicina Nigeria Tamoxifen Interferon Chemotherapy Anticancer drugs The increased use of chemotherapeutic agents hasresulted in longer cancer patient survival.Consequently the ophthalmologist is seeing morepatients with adverse ocular side effects secondaryto these antineoplastic agents. Ocular toxicityinduced by cancer chemotherapy includes a broadspectrum of disorders, reflecting the uniqueanatomical, physiological and biochemical featuresof the eye. Understanding the ocular side effects willassist the ophthalmologist and oncologist torecognize them early and intervene beforeblindness occurs. Anticipation of various treatmentrelatedtoxicities may also provide the opportunityfor pharmacists to develop intervention strategiesthat could minimize or eliminate an expected sideeffect. The ophthalmologist should examine patientson anticancer therapy at baseline and three monthlythereafter. The various ocular side effects ofanticancer chemotherapeutic agents, tamoxifen,and interferon on the adnexia, anterior segment,posterior segment and neuro-ophthalmic structureswere reviewed. 2006 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69040201 https://www.redalyc.org/journal/690/69040201/ https://www.redalyc.org/journal/690/69040201/html/ https://www.redalyc.org/journal/690/69040201/69040201.epub https://www.redalyc.org/journal/690/69040201/movil en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.2 Vol.4
format Artículo científico
id redalyc_69040201
institution Redalyc
language en
publishDate 2006
publisher Centro de investigaciones y Publicaciones Farmacéuticas
spellingShingle Ocular toxicity of systemic anticancer chemotherapy
Afekhide Ernest Omoti
Medicina
Nigeria
Tamoxifen
Interferon
Chemotherapy
Anticancer drugs
Ocular toxicity of systemic anticancer chemotherapy Afekhide Ernest Omoti Caroline Edijana Omoti Medicina Nigeria Tamoxifen Interferon Chemotherapy Anticancer drugs The increased use of chemotherapeutic agents hasresulted in longer cancer patient survival.Consequently the ophthalmologist is seeing morepatients with adverse ocular side effects secondaryto these antineoplastic agents. Ocular toxicityinduced by cancer chemotherapy includes a broadspectrum of disorders, reflecting the uniqueanatomical, physiological and biochemical featuresof the eye. Understanding the ocular side effects willassist the ophthalmologist and oncologist torecognize them early and intervene beforeblindness occurs. Anticipation of various treatmentrelatedtoxicities may also provide the opportunityfor pharmacists to develop intervention strategiesthat could minimize or eliminate an expected sideeffect. The ophthalmologist should examine patientson anticancer therapy at baseline and three monthlythereafter. The various ocular side effects ofanticancer chemotherapeutic agents, tamoxifen,and interferon on the adnexia, anterior segment,posterior segment and neuro-ophthalmic structureswere reviewed. 2006 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69040201 https://www.redalyc.org/journal/690/69040201/ https://www.redalyc.org/journal/690/69040201/html/ https://www.redalyc.org/journal/690/69040201/69040201.epub https://www.redalyc.org/journal/690/69040201/movil en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.2 Vol.4
title Ocular toxicity of systemic anticancer chemotherapy
topic Medicina
Nigeria
Tamoxifen
Interferon
Chemotherapy
Anticancer drugs
url https://www.redalyc.org/articulo.oa?id=69040201
https://www.redalyc.org/journal/690/69040201/
https://www.redalyc.org/journal/690/69040201/html/
https://www.redalyc.org/journal/690/69040201/69040201.epub
https://www.redalyc.org/journal/690/69040201/movil